Provention Bio Inc (PRVB) Return on Assets ROA from the fourth quarter of 2022 to fourth quarter of 2021 and for the year 2022, Average High and Low, Fundamental Ratios from Dec 31 2022 to Dec 31 2021 - CSIMarket
CSIMarket Company Name, Ticker, Customers, else..
 


• ROA Quarterly
• ROI Quarterly
• ROE Quarterly
Provention Bio Inc   (NASDAQ: PRVB)


Provention Bio Inc 's ROA from the fourth quarter of 2022 to the fourth quarter of 2021 and 5 Year Period

Return on Assets, Quarterly Results, Trends, Rankings, Statistics


What is Provention Bio Inc 's ROA in the fourth quarter of 2022?
Provention Bio Inc recorded a cumulative net loss of $-114 million during 12 months ending in the fourth quarter of 2022, resulting in a negative return on assets (ROA) of -68.97%.

However, within the Healthcare sector 974 other companies had a higher return on assets. While return on assets, the total ranking has deteriorated compared to the third quarter of 2022 from 5136 to 5708.

What is ROA?


Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

Return On Assets (Dec 31 2022)
IV. Quarter		 (Sep 30 2022)
III. Quarter		 (Jun 30 2022)
II. Quarter		 (Mar 31 2022)
I. Quarter		 (Dec 31 2021)
IV. Quarter
Y / Y Total Assets Change 74.65 % 23.46 % -43.07 % -42.72 % 5.53 %
Y / Y Net Income Change - - - - -
Net Income (TTM) in million -114 -106 -105 -104 -114
Return On Assets (TTM) -68.97 % -76.16 % -80.34 % -69.39 % -66.28 %
PRVB's Total Ranking # 5708 # 5136 # 5295 # 5166 # 5485
Total Assets (TTM) in million 237 195 104 122 136
Seq. Total Assets Change 21.51 % 86.79 % -14.78 % -9.71 % -14.1 %
Seq. Net Income Change - - - - -

PRVB's 5 Years Annual ROA >> Back to PRVB Management Effectiveness >> Compare PRVB ROA to its Competitors


Return On Assets Company Ranking
Within: No.
Industry # 452
Sector # 975
Overall # 5534

Return On Assets Statistics
High Average Low
-50.44 %
-67.2 %
-80.34 %
(Jun 30 2020)   (Jun 30 2022)





Financial Statements
Provention Bio Inc 's Assets $ 237 million PRVB's Balance sheet
Provention Bio Inc 's Income $ -33 million Quarterly PRVB's Income Statement
PRVB's Income by Division See PRVB's Income by Division



Annual Return On Assets (Dec 31 2022)
FY 2022		 (Dec 31 2021)
FY 2021		 (Dec 31 2020)
FY 2020		 (Dec 31 2019)
FY 2019		 (Dec 31 2018)
FY 2018
Y / Y Total Assets Change 74.65 % 5.53 % 49.45 % 39.76 % -
Total Assets in million 237 136 129 86 62
Y / Y Net Income Change - - - - -
Net Income in million -114 -114 -99 -43 -26
Annual Return On Assets -47.95 % -84.38 % -76.71 % -50.33 % -43.03 %

PRVB's 5 Years Annual ROA >> Back to PRVB Management Effectiveness >> Compare PRVB ROA to its Competitors



More Return On Assets Ratios
PRVB's' Return on Assets at Yahoo Finance
Major Pharmaceutical Preparations Industry Return On Assets Trends and Statistics
Healthcare Sector Roa Statistics
Roa Trends for overall market
PRVB's Roa Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and overall Market
Highest Ranking Return On Assets
Lowest Ranking Return On Assets
Subscribers only: Roa for PRVB's Competitors
Subscribers only: Roa for Provention Bio Inc 's Suppliers
Subscribers only: Return On Assets for PRVB's Customers

You may also want to know
PRVB's Roi PRVB's Inventory Turnover Ratio PRVB's Growth Rates PRVB's Dividend Comparisons
PRVB's Profitability Ratios PRVB's Asset Turnover Ratio PRVB's Dividend Growth
PRVB's Roe PRVB's Valuation Ratios PRVB's Financial Strength Ratios PRVB's Dividend Payout Ratio



Companies with similar Return On Assets at Dec 31 2022, within Healthcare Sector ROA

Date modified: 2026-09-08T15:10:58+00:00


Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.